Capricor Therapeutics Files 8-K on Operations
Ticker: CAPR · Form: 8-K · Filed: May 13, 2025 · CIK: 1133869
| Field | Detail |
|---|---|
| Company | Capricor Therapeutics, Inc. (CAPR) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
TL;DR
Capricor Therapeutics filed an 8-K on May 13, 2025, detailing financial condition and results of operations.
AI Summary
On May 13, 2025, Capricor Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided text excerpt.
Why It Matters
This filing indicates Capricor Therapeutics is providing updates on its financial condition and operational results to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for operational and financial reporting, not indicating any immediate material adverse events.
Key Players & Entities
- CAPRICOR THERAPEUTICS, INC. (company) — Registrant
- May 13, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-34058 (identifier) — Commission File Number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text excerpt does not detail specific financial results or operational updates; it only states that the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was this 8-K report filed by Capricor Therapeutics, Inc.?
The 8-K report was filed on May 13, 2025.
What is the Commission File Number for Capricor Therapeutics, Inc.?
The Commission File Number for Capricor Therapeutics, Inc. is 001-34058.
In which state is Capricor Therapeutics, Inc. incorporated?
Capricor Therapeutics, Inc. is incorporated in Delaware.
What are the main items covered by this 8-K filing?
This 8-K filing covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding CAPRICOR THERAPEUTICS, INC. (CAPR).